EE04241B1 - Apolipoproteiin-B sünteesi inhibiitorid - Google Patents
Apolipoproteiin-B sünteesi inhibiitoridInfo
- Publication number
- EE04241B1 EE04241B1 EE9700093A EE9700093A EE04241B1 EE 04241 B1 EE04241 B1 EE 04241B1 EE 9700093 A EE9700093 A EE 9700093A EE 9700093 A EE9700093 A EE 9700093A EE 04241 B1 EE04241 B1 EE 04241B1
- Authority
- EE
- Estonia
- Prior art keywords
- apolipoprotein
- inhibitors
- synthesis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94203120 | 1994-10-27 | ||
| PCT/EP1995/004111 WO1996013499A1 (en) | 1994-10-27 | 1995-10-19 | Apolipoprotein-b synthesis inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE9700093A EE9700093A (et) | 1997-10-15 |
| EE04241B1 true EE04241B1 (et) | 2004-02-16 |
Family
ID=8217315
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EE9700093A EE04241B1 (et) | 1994-10-27 | 1995-10-19 | Apolipoproteiin-B sünteesi inhibiitorid |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5521186A (et) |
| EE (1) | EE04241B1 (et) |
| MY (1) | MY132062A (et) |
| PL (1) | PL182432B1 (et) |
| RU (1) | RU2144032C1 (et) |
| UA (1) | UA58486C2 (et) |
| ZA (1) | ZA959084B (et) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5703236A (en) * | 1993-12-21 | 1997-12-30 | Schering Corporation | Tetrahydrofuran antifungals |
| CZ286476B6 (en) * | 1994-10-27 | 2000-04-12 | Janssen Pharmaceutica Nv | Heteroaryl substituted derivatives of 1,3-dioxolan-4-ylmethoxyphenyl-1-piperazinylphenyl-2,4-dihydro-2-alkyl-3H-1,2,4-triazol-3-one, process and intermediates for their preparation and pharmaceutical preparations containing thereof |
| DE19638245A1 (de) | 1996-09-19 | 1998-03-26 | Basf Ag | Substituierte Carbamoyltriazole und ihre Verwendung als Herbizide |
| JP2001521899A (ja) * | 1997-11-03 | 2001-11-13 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 脂質低下剤組成物 |
| US7649002B2 (en) | 2004-02-04 | 2010-01-19 | Pfizer Inc | (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists |
| US7262318B2 (en) * | 2004-03-10 | 2007-08-28 | Pfizer, Inc. | Substituted heteroaryl- and phenylsulfamoyl compounds |
| US20050288340A1 (en) * | 2004-06-29 | 2005-12-29 | Pfizer Inc | Substituted heteroaryl- and phenylsulfamoyl compounds |
| PA8660701A1 (es) | 2005-02-04 | 2006-09-22 | Pfizer Prod Inc | Agonistas de pyy y sus usos |
| CA2609783A1 (en) * | 2005-05-27 | 2006-12-07 | Pfizer Products Inc. | Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss |
| WO2007015162A1 (en) * | 2005-08-04 | 2007-02-08 | Pfizer Limited | Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds |
| US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
| US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| MEP6808A (xx) * | 2006-02-23 | 2010-02-10 | Lundbeck & Co As H | Priperidinoilpirodolini agonisti receptora menalokortina tipa 4 |
| US8383660B2 (en) | 2006-03-10 | 2013-02-26 | Pfizer Inc. | Dibenzyl amine compounds and derivatives |
| CN101583593A (zh) | 2006-11-13 | 2009-11-18 | 辉瑞产品公司 | 二芳基、二吡啶基和芳基-吡啶基衍生物及其用途 |
| JP5498168B2 (ja) | 2006-12-01 | 2014-05-21 | ブリストル−マイヤーズ スクイブ カンパニー | アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体 |
| ES2421920T3 (es) * | 2008-08-06 | 2013-09-06 | Pfizer Ltd | Compuestos de diazepina y diazocano como agonistas de MC4 |
| US9663499B2 (en) | 2013-06-07 | 2017-05-30 | The California Institute For Biomedical Research | Small molecule inhibitors of fibrosis |
| WO2016094570A1 (en) * | 2014-12-10 | 2016-06-16 | The California Institute For Biomedical Research | Small molecule inhibitors of fibrosis |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4218458A (en) * | 1978-06-23 | 1980-08-19 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles |
| CA1331757C (en) * | 1988-02-29 | 1994-08-30 | Janssen Pharmaceutica Naamloze Vennootschap | 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols |
-
1995
- 1995-05-31 US US08/455,304 patent/US5521186A/en not_active Expired - Lifetime
- 1995-10-19 RU RU97108168A patent/RU2144032C1/ru not_active IP Right Cessation
- 1995-10-19 EE EE9700093A patent/EE04241B1/et not_active IP Right Cessation
- 1995-10-19 UA UA97052120A patent/UA58486C2/uk unknown
- 1995-10-19 PL PL95319905A patent/PL182432B1/pl not_active IP Right Cessation
- 1995-10-26 ZA ZA959084A patent/ZA959084B/xx unknown
- 1995-10-27 MY MYPI95003246A patent/MY132062A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL319905A1 (en) | 1997-09-01 |
| EE9700093A (et) | 1997-10-15 |
| RU2144032C1 (ru) | 2000-01-10 |
| US5521186A (en) | 1996-05-28 |
| MY132062A (en) | 2007-09-28 |
| ZA959084B (en) | 1997-04-29 |
| PL182432B1 (pl) | 2002-01-31 |
| UA58486C2 (uk) | 2003-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI971784A (fi) | Apolipoproteiini B-synteesin estäjiä | |
| FI963597A (fi) | Isoprenyylitransferaasi-inhibiittoreita | |
| NO972930D0 (no) | Fibronectin-adhesjonsinhibitorer | |
| LV11178A (lv) | 3-Ú4-(2-aminoetoksi) benzoil¾-2-aril-6-hidroksibenzoÚb¾tiofenu sintezes panemiens | |
| FI972160A (fi) | Matriisimetalloproteaasi-inhibiittorit | |
| DE69608448D1 (de) | Reduktion des biobewuchses | |
| IS4771A (is) | Interlevkín-1ß umbreytiensím tálmar | |
| CY2012029I2 (el) | Nεα μορφη της 5-ομεπραζολης | |
| EE9700093A (et) | Apolipoproteiin-B sünteesi inhiibitorid | |
| ATE230275T1 (de) | Angiogense-inhibitor | |
| PT927183E (pt) | Inibidores espirociclicos de metaloproteases | |
| DE69531048D1 (de) | Verwendung von steroidsulphatase-hemmern | |
| ID24270A (id) | Penghilang sumbatan keratotik | |
| DE69632435D1 (de) | Inhibitor des Hepatozytwachstumsfaktoraktivators | |
| NO990832D0 (no) | Syntese av bisendolylmalimider | |
| ID23437A (id) | Penghilang sumbatan keratotik | |
| IT1293320B1 (it) | Miscela di stabilizzanti | |
| DE69631500D1 (de) | Inhibitor des Hepatozytwachstumsfaktoraktivators | |
| BR9610514A (pt) | Inibidores cicloantihelmínticos | |
| FI963743A0 (fi) | Reniini-inhibiittorien prototyyppien synteesi | |
| CY2007006I1 (el) | Αναστολεις συνθεσης απολιποπρωτεινης-β | |
| KR950024188U (ko) | 갈치주낚용 도래의 고정구 | |
| ID17328A (id) | Pemurnian epsilon-kaprolaktam | |
| IS4339A (is) | Hömlun ljóssundurliðunar á 3-setnum-2-oxindólum | |
| KR970011853U (ko) | 새로운 형태의 메리야스 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB4A | Valid patent at the end of a year |
Effective date: 20041231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20051231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20061231 |
|
| AA1Y | Spc filed |
Free format text: PRODUCT NAME: YARVITAN - MITRATAPIID; REG NO/DATE: EU/2/06/063/001 14.11.2006 EU/2/06/063/002 14.11.2006 EU/2/06/063/003 14.11.2006 Spc suppl protection certif: C20070001 Filing date: 20070213 |
|
| FG1Y | Spc granted |
Free format text: PRODUCT NAME: YARVITAN - MITRATAPIID; REG NO/DATE: EU/2/06/063/001 14.11.2006 EU/2/06/063/002 14.11.2006 EU/2/06/063/003 14.11.2006 Spc suppl protection certif: C20070001 00012 Filing date: 20070213 Extension date: 20201019 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20071231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20101231 |
|
| GB1A | Change in the ownership or in the address of the owner | ||
| MC1Y | Annulment of an spc |
Spc suppl protection certif: 00012 |
|
| MM4A | Lapsed by not paying the annual fees |
Effective date: 20121019 |